A case report of peroneal muscle atrophy type 2A2 with central nervous system involvement as initial presentation

• Published in: BMC pediatrics 2024-01, Vol.24 (1), p.21-21, Article 21
• Main Authors: Xu, Xin, Lu, Fen, Du, Senjie, Zhang, Li
• Format: Article
• Language: English
• Subjects: Atrophy; Case reports; Central nervous system; Cerebral nervous system; Charcot-Marie-Tooth disease; Charcot-Marie-Tooth disease type 2A2; Children; Children & youth; Demographic aspects; Diagnosis; Health aspects; Magnetic resonance imaging; Metabolism; MFN2; Muscle strength; Mutation; Patients; Pediatrics; Proteins; Rehabilitation
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-023-04441-z

Charcot-Marie-Tooth disease (CMT) is a group of single-gene hereditary diseases of peripheral nerve with high clinical variability and genetic heterogeneity. The typical clinical manifestations include progressive muscle weakness and muscle atrophy in the distal extremities, accompanied by disappearance of tendon reflexes and distal sensory disturbances. CMT2A2 (OMIM: 609260) is caused by the mutation of MFN2 (OMIM: 608507), is the most common type of axonal pattern. Although a small number of patients with X-linked CMT1 (CMT1X) present with central nervous system involvement, including reversible white matter lesions, it is rarely in CMT2A2. A 3-year and 5-month-old girl had experienced motor lag, muscle tension, and abnormal gait for over a year. A reexamination of cranial MRI revealed an anterior enlargement of the abnormal signal range in the lateral ventricles and bilateral frontal lobes. And the whole exon sequencing showed that this girl carried a heterozygous missense mutation c.314C > T of MNF2 gene, inherited from her mother. In this study, we retrospectively analyzed the clinical and molecular genetic findings of a child with Charcot-Marie-Tooth disease A2 with central nervous system involvement as the initial presentation, and explored its pathogenic mechanism.